Lansdowne Partners Austria’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Lansdowne Partners Austria’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$1.19M	Hold	1,693,833	–	–	4.08%	2
2015 Q3	$2.08M	Hold	1,693,833	–	–	90.89%	1
2015 Q2	$1.85M	Hold	1,693,833	–	–	82.93%	1
2015 Q1	$3.51M	Hold	1,693,833	–	–	80.6%	1
2014 Q4	$2.52M	Hold	1,693,833	–	–	74.87%	1
2014 Q3	$3.95M	Buy	1,693,833 +267,598	+19%	+$1.02M	80.83%	1
2014 Q2	$6.52M	Buy	1,426,235 +70,980	+5%	+$306K	100%	1
2014 Q1	$6M	Hold	1,355,255	–	–	100%	1
2013 Q4	$6.41M	Hold	1,355,255	–	–	100%	1
2013 Q3	$6.94M	Buy	1,355,255 +142,700	+12%	+$671K	100%	1
2013 Q2	$5.26M	Buy	+1,212,555	New	+$5.5M	100%	1

Other funds holding ALXA

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lansdowne Partners Austria's ALXA Position: Q4 2015 in Review

Lansdowne Partners Austria held its Alexza Pharmaceuticals Inc (ALXA) position steady in Q4 2015 at 1,693,833 shares worth $1.19M. The position accounts for 4.08% of the portfolio, ranked #2.

Lansdowne Partners Austria first reported a position in ALXA in Q2 2013 and has held it in 11 quarters since. The position peaked at $6.94M in Q3 2013. 26 funds tracked by Wall St. Rank hold ALXA as of Q4 2015.

Lansdowne Partners Austria held 1,693,833 shares of Alexza Pharmaceuticals Inc worth $1.19M as of Q4 2015.
Lansdowne Partners Austria left its Alexza Pharmaceuticals Inc share count unchanged in Q4 2015.
Alexza Pharmaceuticals Inc made up 4.08% of Lansdowne Partners Austria's portfolio in Q4 2015, its #2 holding.
Lansdowne Partners Austria first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and has held it in 11 quarters since.
Lansdowne Partners Austria's Alexza Pharmaceuticals Inc position peaked at $6.94M in Q3 2013.
26 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q4 2015.

Based on Lansdowne Partners Austria's 13F filing for Q4 2015, filed 12 Feb 2016.